GCM
DPLO

Glaxis Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Glaxis Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,000
Closed -$346K – 26
2015
Q1 		$346K Buy
+10,000
New +$272K 0.64% 27

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Glaxis Capital Management's DPLO Position: Q2 2015 in Review

Glaxis Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2015, closing a stake of 10,000 shares — an estimated $346K sold.

Glaxis Capital Management first reported a position in DPLO in Q1 2015 and held it in 1 quarter. The position peaked at $346K in Q1 2015. 126 funds tracked by Wall St. Rank hold DPLO as of Q2 2015.

  • Glaxis Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2015 after selling out during the quarter.
  • Glaxis Capital Management sold 10,000 DIPLOMAT PHARMACY, INC. shares in Q2 2015, an estimated $346K.
  • Glaxis Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 1 quarter.
  • Glaxis Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $346K in Q1 2015.
  • 126 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2015.

Based on Glaxis Capital Management's 13F filing for Q2 2015, filed 8 Jul 2015.